1375 related articles for article (PubMed ID: 18663473)
1. Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson's Disease: implications for limbic system and basal ganglia interactions.
Turner MS; Gray TS; Mickiewicz AL; Napier TC
Brain Struct Funct; 2008 Sep; 213(1-2):197-213. PubMed ID: 18663473
[TBL] [Abstract][Full Text] [Related]
2. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
McPherson RJ; Marshall JF
Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease.
Ochi M; Shiozaki S; Kase H
Neuroscience; 2004; 127(1):223-31. PubMed ID: 15219684
[TBL] [Abstract][Full Text] [Related]
4. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
[TBL] [Abstract][Full Text] [Related]
5. Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function.
Heidenreich BA; Mitrovic I; Battaglia G; Napier TC
Exp Neurol; 2004 Apr; 186(2):145-57. PubMed ID: 15026253
[TBL] [Abstract][Full Text] [Related]
6. Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat model.
Breit S; Lessmann L; Unterbrink D; Popa RC; Gasser T; Schulz JB
Eur J Neurosci; 2006 Oct; 24(8):2275-82. PubMed ID: 17042796
[TBL] [Abstract][Full Text] [Related]
7. Induction of Fos-like immunoreactivity in the basal ganglia by ether anaesthesia: effects of injections of muscimol in rostral versus caudal substantia nigra pars reticulata.
Shehab SA; Julyan TE
Exp Brain Res; 2002 Jan; 142(2):227-40. PubMed ID: 11807577
[TBL] [Abstract][Full Text] [Related]
8. Levodopa induction of Fos immunoreactivity in rat brain following partial and complete lesions of the substantia nigra.
Cole DG; Growdon JH; DiFiglia M
Exp Neurol; 1993 Apr; 120(2):223-32. PubMed ID: 8491280
[TBL] [Abstract][Full Text] [Related]
9. Behavioural disorders induced by external globus pallidus dysfunction in primates II. Anatomical study.
François C; Grabli D; McCairn K; Jan C; Karachi C; Hirsch EC; Féger J; Tremblay L
Brain; 2004 Sep; 127(Pt 9):2055-70. PubMed ID: 15292054
[TBL] [Abstract][Full Text] [Related]
10. Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model.
Blandini F; Levandis G; Bazzini E; Nappi G; Armentero MT
Eur J Neurosci; 2007 Jan; 25(2):397-405. PubMed ID: 17284180
[TBL] [Abstract][Full Text] [Related]
11. Effects of NMDA and MK-801 injected into the substantia nigra pars reticulata on jaw movements evoked by dopamine D1-/D2 receptor stimulation in the ventrolateral striatum: studies in freely moving rats.
Uchida T; Lee J; Fujita S; Kiguchi M; Matsumoto M; Oi Y; Gionhaku N; Koshikawa N
Methods Find Exp Clin Pharmacol; 2005; 27(1):31-7. PubMed ID: 15834457
[TBL] [Abstract][Full Text] [Related]
12. Basal ganglia neural responses during behaviorally effective deep brain stimulation of the subthalamic nucleus in rats performing a treadmill locomotion test.
Shi LH; Luo F; Woodward DJ; Chang JY
Synapse; 2006 Jun; 59(7):445-57. PubMed ID: 16521122
[TBL] [Abstract][Full Text] [Related]
13. Distinct Fos expression in the brain following freezing behavior elicited by stimulation with NMDA of the ventral or dorsal inferior colliculus.
Ferreira-Netto C; Borelli KG; Brandão ML
Exp Neurol; 2007 Apr; 204(2):693-704. PubMed ID: 17289027
[TBL] [Abstract][Full Text] [Related]
14. Genetics ethanol and the Fos response: a comparison of the C57BL/6J and DBA/2J inbred mouse strains.
Hitzemann B; Hitzemann R
Alcohol Clin Exp Res; 1997 Nov; 21(8):1497-507. PubMed ID: 9394124
[TBL] [Abstract][Full Text] [Related]
15. Differential role of GABAA and GABAB receptors in two distinct output stations of the rat striatum: studies on the substantia nigra pars reticulata and the globus pallidus.
Ikeda H; Kotani A; Koshikawa N; Cools AR
Neuroscience; 2010 Apr; 167(1):31-9. PubMed ID: 20132872
[TBL] [Abstract][Full Text] [Related]
16. Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat.
Breit S; Bouali-Benazzouz R; Popa RC; Gasser T; Benabid AL; Benazzouz A
Exp Neurol; 2007 May; 205(1):36-47. PubMed ID: 17395181
[TBL] [Abstract][Full Text] [Related]
17. Differential vulnerability of hippocampus, basal ganglia, and prefrontal cortex to long-term NMDA excitotoxicity.
Bernal F; Saura J; Ojuel J; Mahy N
Exp Neurol; 2000 Feb; 161(2):686-95. PubMed ID: 10686087
[TBL] [Abstract][Full Text] [Related]
18. Activation of feeding-related neural circuitry after unilateral injections of muscimol into the nucleus accumbens shell.
Stratford TR
Brain Res; 2005 Jun; 1048(1-2):241-50. PubMed ID: 15921658
[TBL] [Abstract][Full Text] [Related]
19. Subthalamic nucleus lesions alter basal and dopamine agonist stimulated electrophysiological output from the rat basal ganglia.
Zahr NM; Martin LP; Waszczak BL
Synapse; 2004 Nov; 54(2):119-28. PubMed ID: 15352137
[TBL] [Abstract][Full Text] [Related]
20. Bilateral changes in neuronal activity of the basal ganglia in the unilateral 6-hydroxydopamine rat model.
Breit S; Martin A; Lessmann L; Cerkez D; Gasser T; Schulz JB
J Neurosci Res; 2008 May; 86(6):1388-96. PubMed ID: 18061958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
